NEUROLITE
NEUROLITE Kit for the Preparation of Technetium Tc99m Bicisate for InjectionFOR DIAGNOSTIC USE
Approved
Approval ID
f9adbcd5-1ac1-42d8-b18a-a76c9204014c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 18, 2022
Manufacturers
FDA
Lantheus Medical Imaging, Inc.
DUNS: 176786812
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Bicisate dihydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code11994-006
Application NumberNDA020256
Product Classification
M
Marketing Category
C73594
G
Generic Name
Bicisate dihydrochloride
Product Specifications
Effective DateNovember 18, 2022
FDA Product Classification